Why Did Cara Therapeutics Shares Tumble 13.6% in April? – Motley Fool


Motley Fool
Why Did Cara Therapeutics Shares Tumble 13.6% in April?
Motley Fool
What happened. Following a stock offering that diluted investors and ahead of first-quarter financial results, shares in Cara Therapeutics (NASDAQ:CARA) lost 13.6% of their value in April, according to S&P Global Market Intelligence.

and moreĀ >>

Source: shares – Google News

Sharing information is key – Share Dealing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd